Laurus Labs Share Price
(LAURUSLABS)
Check the latest share price of Laurus Labs, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹617.45
as on 04:01PM, 29 Apr 2025
NSE
Laurus Labs Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹614.35Day's Price Range₹63352 Week's Low
52 Week's High
₹385.4552-Week Price Range₹660.9
| Returns % | |
| 1 Month Return | + 4.21 % |
| 3 Month Return | + 8.79 % |
| 1 Year Return | + 40.91 % |
| Market Stats | |
| Previous Close | ₹626.50 |
| Open | ₹630.00 |
| Volume | 23.63L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹32,670.61Cr |
Laurus Labs Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹32,670.61 Cr
Return on Equity (ROE)
24.59
Return on capital employed (ROCE)
22.71
P/B Ratio
9.36
Dividend Yield
0.34
EPS (TTM)
15.49
Sector
Pharmaceuticals
How to invest in Laurus Labs
Investing in Laurus Labs is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Laurus Labs or LAURUSLABS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Laurus Labs or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Laurus Labs with just a few clicks!
Laurus Labs Valuation
Track how the P/E of Laurus Labs has moved over time to understand valuation trends.
Laurus Labs in the last 5 years
Lowest (16.96x)
March 28, 2023
Today (56.47x)
December 15, 2023
Industry (58.33x)
December 15, 2023
Highest (193.71x)
September 18, 2020
Today’s Price to Earnings Ratio: 56.47x
Analysts Recommendation on Laurus Labs
Get updated buy, sell, and hold recommendations by analysts on Laurus Labs.
based on 11 analysts
36.36%
Buy
27.27%
Hold
36.36%
Sell
36.36% of analysts recommend a 'HOLD' rating for Laurus Labs. Average target of ₹345.91
Source: S&P Global Market Intelligence
Analysts Forecast on Laurus Labs
Get share price movements and forecasts by analysts on Laurus Labs.
Laurus Labs price forecast by 11 analysts
Downside of
High
₹475
Target
₹345.91
Low
₹250
Laurus Labs target price ₹345.91, a slight downside of -42.91% compared to current price of ₹617.45. According to 11 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Laurus Labs revenue growth forecast
Expected growth rate Q1, FY2025:11.24%
Forecast
Actual
Including amortisation and stock based compensations
Laurus Labs EPS growth forecast
EPS estimate Q1, FY2025:1.91%
Forecast
Actual
Source: S&P Global Market Intelligence
Laurus Labs Financials
Get the annual and quarterly financial summary of Laurus Labs, including revenue, profit, loss and more.
Laurus Labs Index Inclusions
Laurus Labs Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Laurus Labs.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 27.2% | 0.00 | |
| Foreign Institutions | 22.42% | 0.00 | |
| Mutual Funds | 5.4% | 0.00 | |
| Retail Investors | 40.64% | 0.00 | |
| Others | 4.34% | 0.00 |
Laurus Labs vs Peers
Compare market cap, revenue, PE, and other key metrics of Laurus Labs with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹32,670.61 Cr | 131.01% | 0.67 | NA | NA | |
| ₹22,584.81 Cr | 16.09% | 0.63 | NA | NA | ||
| ₹58,436.80 Cr | 16.38% | 0.61 | NA | NA | ||
| BUY | ₹9,908.51 Cr | 11.14% | 0.64 | NA | NA | |
| BUY | ₹3,718.29 Cr | 6.87% | 0.52 | NA | NA |
Laurus Labs News & Key Events
Latest news and events at one place to help you take investing decisions in Laurus Labs.
Laurus Labs Targets Strong EBITDA Margins by FY26 - 26 Apr, 2025
Laurus Labs projects EBITDA margins of 24-24.5% in FY26, driven by strong demand in the CDMO segment. The company reported a significant rise in Q4 FY25 margins to 27.7%, up from 18% year-on-year, indicating robust revenue growth.Laurus Labs Reports Strong Growth Amid Mixed Market Reactions - 25 Apr, 2025
Laurus Labs showcases impressive Q4 results with 210% net profit growth. Analysts maintain a positive outlook with target prices of Rs 750, despite a downgrade from Jefferies due to ARV concerns. The stock faces volatility, dropping 6% despite strong performance.Laurus Labs Reports Strong Q4 Results and Dividend - 24 Apr, 2025
Laurus Labs announced a three-fold increase in Q4 profit to ₹234 crore, with revenue at ₹1,720 crore. The board approved a second interim dividend of ₹0.80 per share for FY25.Laurus Labs Invests in Cell and Gene Therapies - 22 Apr, 2025
Laurus Labs is investing Rs 550 crore in cell and gene therapies, aiming to become a key CDMO partner. The company is focusing on disruptive technologies and collaborations to leverage India's manufacturing capabilities for global markets.Laurus Labs Receives USFDA EIR for API Facility - 15 Apr, 2025
Laurus Labs has received the Establishment Inspection Report (EIR) from the USFDA for its API manufacturing facility (Unit-4) in Atchutapuram, confirming compliance with US regulatory requirements.Laurus Labs Records Significant Intraday Surge - 11 Apr, 2025
Laurus Labs shares rose 8%, achieving the highest intraday gain since January 30, 2025. The company anticipates robust growth in its CDMO divisions for Q4FY25E.Laurus Labs Shares Fall Amid Tax Comments - 07 Apr, 2025
On April 7, 2025, shares of Laurus Labs Ltd and other Indian pharmaceutical companies fell by up to 8% due to US President Trump's remarks regarding impending taxes on the pharmaceutical sector.Laurus Labs Faces Significant Stock Decline Amid Tariff Concerns - 04 Apr, 2025
Laurus Labs announced a ₹5,000 crore investment in a new manufacturing facility, but shares plummeted 9.5% due to tariff concerns, reflecting broader market losses in the pharma sector.Laurus Labs Acquires Stake in Kurnool Renewables - 28 Mar, 2025
Laurus Labs has approved the acquisition of up to 26% stake in Kurnool Renewables for Rs 35 crore. This strategic investment aims to enhance access to renewable energy, reduce electricity costs, and support ESG objectives.
Insights on Laurus Labs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, 12.51 Cr → 233.67 Cr (in ₹), with an average increase of 58.7% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, LAURUSLABS stock has moved up by 15.2%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 1.19K Cr → 1.77K Cr (in ₹), with an average increase of 12.1% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 34.08% to 35.09% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 129.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 27.62% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 9.9%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 7.62% to 6.88% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 25.56% to 25.52% in Mar 2025 quarter
About Laurus Labs
Revenue: ₹1,194.91Cr as on June 2024 (Q2 24)
Net Profit: ₹12.21Cr as on June 2024 (Q2 24)
Listing date: 19 Dec, 2016
Chairperson Name: M V G Rao
| Organisation | Laurus Labs |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Laurus Labs
Check out the Mutual Funds with significant holdings in Laurus Labs.
Futures and Options
View the latest movement in Laurus Labs Futures & Options, including strike prices, expiry dates, and percentage changes.
FAQs
What is Laurus Labs Ltd price today?
Laurus Labs Ltd share price today stands at ₹617.45, Open: ₹630, Previous Close: ₹626.5, High: ₹633, Low: ₹614.35, 52 Week High: ₹660.9, 52 Week Low: ₹385.45.
How to Buy Laurus Labs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Laurus Labs Ltd shares
What are today's traded volumes of Laurus Labs Ltd?
Today's traded volume of Laurus Labs Ltd(LAURUSLABS) is 23.63L.
What is today's market capitalisation of Laurus Labs Ltd?
Today's market capitalisation of Laurus Labs Ltd(LAURUSLABS) is ₹32,670.61 Cr.
What is the 52 Week High and Low Range of Laurus Labs Ltd?
How much percentage Laurus Labs Ltd is down from its 52 Week High?
Laurus Labs Ltd (LAURUSLABS) share price is ₹617.45. It is down -6.57% from its 52 Week High price of ₹660.9
How much percentage Laurus Labs Ltd is up from its 52 Week low?
Laurus Labs Ltd (LAURUSLABS) share price is ₹617.45. It is up 60.19% from its 52 Week Low price of ₹385.45